Research identifies new target that may prevent blood cancer

An international coalition of biomedical researchers co-led by Alexander Bick, MD, Ph.D., at Vanderbilt University Medical Center has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup